全文获取类型
收费全文 | 270775篇 |
免费 | 20384篇 |
国内免费 | 7892篇 |
专业分类
耳鼻咽喉 | 3448篇 |
儿科学 | 4611篇 |
妇产科学 | 4542篇 |
基础医学 | 34331篇 |
口腔科学 | 5240篇 |
临床医学 | 27226篇 |
内科学 | 46357篇 |
皮肤病学 | 5686篇 |
神经病学 | 17471篇 |
特种医学 | 12732篇 |
外国民族医学 | 27篇 |
外科学 | 34823篇 |
综合类 | 23408篇 |
现状与发展 | 31篇 |
一般理论 | 88篇 |
预防医学 | 19116篇 |
眼科学 | 6353篇 |
药学 | 24768篇 |
109篇 | |
中国医学 | 7902篇 |
肿瘤学 | 20782篇 |
出版年
2024年 | 418篇 |
2023年 | 2114篇 |
2022年 | 5772篇 |
2021年 | 9155篇 |
2020年 | 5753篇 |
2019年 | 6253篇 |
2018年 | 7281篇 |
2017年 | 6303篇 |
2016年 | 7195篇 |
2015年 | 10318篇 |
2014年 | 12943篇 |
2013年 | 14669篇 |
2012年 | 22047篇 |
2011年 | 22320篇 |
2010年 | 15147篇 |
2009年 | 12854篇 |
2008年 | 17072篇 |
2007年 | 16861篇 |
2006年 | 15327篇 |
2005年 | 14260篇 |
2004年 | 11800篇 |
2003年 | 10607篇 |
2002年 | 9164篇 |
2001年 | 6681篇 |
2000年 | 5784篇 |
1999年 | 4413篇 |
1998年 | 2056篇 |
1997年 | 1744篇 |
1996年 | 1450篇 |
1995年 | 1310篇 |
1994年 | 1127篇 |
1993年 | 888篇 |
1992年 | 1785篇 |
1991年 | 1758篇 |
1990年 | 1489篇 |
1989年 | 1351篇 |
1988年 | 1238篇 |
1987年 | 1108篇 |
1986年 | 1095篇 |
1985年 | 927篇 |
1984年 | 702篇 |
1983年 | 594篇 |
1982年 | 428篇 |
1981年 | 406篇 |
1980年 | 363篇 |
1979年 | 539篇 |
1978年 | 429篇 |
1977年 | 401篇 |
1976年 | 353篇 |
1974年 | 375篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
35.
36.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献
37.
目的 分析新型冠状病毒肺炎(以下简称新冠肺炎)疫情对天津市无偿献血的影响.方法 回顾性分析该市2020年无偿献血人次及献血量,并与2019年献血情况进行对比;分析2020年春节前后及2019年同期的献血情况.结果 2020年捐献全血和单采血小板的总人次较2019年均下降13.03%,献血量分别下降17.60%、10.37%.2020年与2019年春节期间捐献全血和单采血小板的人次和献血量均明显下降,但2020年献血情况持续受疫情影响.2020年1-6月全血和单采血小板的献血情况较2019年同期下降较为明显,2020年7-12月的献血情况好转,与2019年同期差距减小.结论 新冠肺炎疫情对无偿献血工作提出严峻考验.常态化疫情防控期间,分析研判疫情对无偿献血工作的影响,有利于制订更有效的预防措施抗击疫情,保障临床用血. 相似文献
38.
Chih-Wei Hsu Sheng-Yu Lee Yao-Hsu Yang Liang-Jen Wang 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2020,23(10):653
BackgroundGeneric antidepressants are approved on the market based on evidence of bioequivalence to their brand-name versions. We aimed to assess whether generic antidepressants exert equal effectiveness as their brand-name counterparts for treating patients with depressive disorders.MethodsIn a nationwide, population-based cohort in Taiwan from 1997 through 2013, patients with a diagnosis of a depressive disorder aged between 18 and 65 years who were new users of antidepressant drugs were classified into either the brand-name group or the generic group. All patients were followed up until medication discontinuation or the end of the study period. We assessed the risk for hospitalization as a primary outcome and augmentation therapy, daily dose, medication discontinuation, or switching to another antidepressant as secondary outcomes.ResultsA total of 277 651 brand-name users (35.8% male; mean age: 41.2 years) and 270 583 generic users (35.8% male; mean age: 41.0 years) were divided into 10 different antidepressant groups (fluoxetine, sertraline, paroxetine, escitalopram, citalopram, venlafaxine, mirtazapine, moclobemide, imipramine, and bupropion). We found that patients treated with the generic form of sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine, and bupropion demonstrated significantly higher risks of psychiatric hospitalization (adjusted hazard ratios ranged from 1.20–2.34), compared to their brand-name counterparts. The differences between brand-name antidepressants and their generic counterparts in secondary outcomes varied across different drugs.ConclusionsCompared to most generic antidepressants, brand-name drugs exhibited more protective effects on psychiatric hospitalization for depressive patients. These findings could serve as an important reference for clinicians when encountering patients with depressive disorder. 相似文献
39.
目的:探讨TomoTherapy QualityAssurance(TQA)数据趋势与螺旋断层放疗(Helical Tomotherapy,HT)系统输出的
联系。方法:回顾性分析了本院HT系统近3年内TQA各个模块的参数和数据趋势,探讨其与HT系统的静态输出剂量和
输出能量(D20/D10)变化的相关性。结果:楔形阶梯静态模块的z轴偏移参数与HT的静态输出剂量的相关性最强(r=0.883,
P<0.01)。基本剂量测定模块的出口检测器平整度值对能量变化最敏感(r=0.902),其次是楔形阶梯静态模块的能量差异
(r=0.897)和楔形阶梯螺旋模块的能量差异(r=0.852),灵敏度分别为2.3×10-4、3.1×10-4和5.7×10-4。结论:TQA有助于用户
追踪HT输出剂量和能量变化,及早进行必要的机器维护或剂量校准。 相似文献
40.